Erythrodysesthesia: An Unusual Complication With Trastuzumab Monotherapy

Palmar-plantar erythrodysesthesia (PPE), more commonly known as hand-foot syndrome, is a dermatologic complication following chemotherapy with selective agents. In this article, we present the case of a young lady with stage III breast cancer who developed palmar-plantar erythrodysesthesia following...

Descripción completa

Detalles Bibliográficos
Autores principales: Fontenot, Andee L, Furr, Weldon J, Husan, Ammar, Khan, Muhammad W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720033/
https://www.ncbi.nlm.nih.gov/pubmed/34993032
http://dx.doi.org/10.7759/cureus.20060
_version_ 1784625066425712640
author Fontenot, Andee L
Furr, Weldon J
Husan, Ammar
Khan, Muhammad W
author_facet Fontenot, Andee L
Furr, Weldon J
Husan, Ammar
Khan, Muhammad W
author_sort Fontenot, Andee L
collection PubMed
description Palmar-plantar erythrodysesthesia (PPE), more commonly known as hand-foot syndrome, is a dermatologic complication following chemotherapy with selective agents. In this article, we present the case of a young lady with stage III breast cancer who developed palmar-plantar erythrodysesthesia following treatment with Herceptin (trastuzumab), an unusual complication of this particular drug. From our review of literature, this is the second known occurrence of PPE secondary to trastuzumab monotherapy.
format Online
Article
Text
id pubmed-8720033
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-87200332022-01-05 Erythrodysesthesia: An Unusual Complication With Trastuzumab Monotherapy Fontenot, Andee L Furr, Weldon J Husan, Ammar Khan, Muhammad W Cureus Family/General Practice Palmar-plantar erythrodysesthesia (PPE), more commonly known as hand-foot syndrome, is a dermatologic complication following chemotherapy with selective agents. In this article, we present the case of a young lady with stage III breast cancer who developed palmar-plantar erythrodysesthesia following treatment with Herceptin (trastuzumab), an unusual complication of this particular drug. From our review of literature, this is the second known occurrence of PPE secondary to trastuzumab monotherapy. Cureus 2021-11-30 /pmc/articles/PMC8720033/ /pubmed/34993032 http://dx.doi.org/10.7759/cureus.20060 Text en Copyright © 2021, Fontenot et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Family/General Practice
Fontenot, Andee L
Furr, Weldon J
Husan, Ammar
Khan, Muhammad W
Erythrodysesthesia: An Unusual Complication With Trastuzumab Monotherapy
title Erythrodysesthesia: An Unusual Complication With Trastuzumab Monotherapy
title_full Erythrodysesthesia: An Unusual Complication With Trastuzumab Monotherapy
title_fullStr Erythrodysesthesia: An Unusual Complication With Trastuzumab Monotherapy
title_full_unstemmed Erythrodysesthesia: An Unusual Complication With Trastuzumab Monotherapy
title_short Erythrodysesthesia: An Unusual Complication With Trastuzumab Monotherapy
title_sort erythrodysesthesia: an unusual complication with trastuzumab monotherapy
topic Family/General Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720033/
https://www.ncbi.nlm.nih.gov/pubmed/34993032
http://dx.doi.org/10.7759/cureus.20060
work_keys_str_mv AT fontenotandeel erythrodysesthesiaanunusualcomplicationwithtrastuzumabmonotherapy
AT furrweldonj erythrodysesthesiaanunusualcomplicationwithtrastuzumabmonotherapy
AT husanammar erythrodysesthesiaanunusualcomplicationwithtrastuzumabmonotherapy
AT khanmuhammadw erythrodysesthesiaanunusualcomplicationwithtrastuzumabmonotherapy

Ejemplares similares